United StatesNystatin Cream, USP, 15 g per tube (prescription only), NDC 51672-1289-1, manufactured by Taro Pharmaceutical Industries Ltd. (Haifa Bay, Israel) and distributed by Taro Pharmaceuticals U.S.A., Inc., lots AD49605 and AD49606, exp. 05/31/2027, sold nationwide in the U.S. is affected. Sun Pharmaceutical Industries Inc. recalled the product because it failed stability specifications.
What's being recalled
Nystatin Cream, USP, 15 g per tube, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761; Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-1289-1
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
LOT AD49605, LOT AD49606; Exp. 05/31/2027
The hazard
Failed Stability Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)